fig2
![MRI for screening and surveillance for hepatocellular cancer in NAFLD and NASH](https://image.oaes.cc/33f89a0b-e3ea-441f-860a-c9de2554ab2e/5775.fig.2.jpg)
Figure 2. HCC in Segment 7 using Gadavist, ECA. Non-contrast image shows a mass of low signal; Arterial non-rim enhancement; Portal-venous central washout with a capsule; Delayed imaging at 5 minutes shows further washout.
Figure 2. HCC in Segment 7 using Gadavist, ECA. Non-contrast image shows a mass of low signal; Arterial non-rim enhancement; Portal-venous central washout with a capsule; Delayed imaging at 5 minutes shows further washout.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/